Shares of Lupin will remain in focus, following the company receiving approval from the USFDA for its generic version of Warner Chilcott’s oral contraceptive tablets Loestrin in two strengths. Lup…
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
